Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Adv Ther (Weinh). 2021 Oct 8;5(1):2100100. doi: 10.1002/adtp.202100100

Table 1.

LC50 of MCL and its analogs against M9-ENL1 and MV411 cells.

Class Compound CLogP1 LC50 [μM] M9-ENL1 LC50 [μM]2 MV-411
Parent MCL 1.7 15.4 ± 1.1 5.6 ± 2.8
Esters MCL-6 2.8 20 ± 3 1.4 ± 0.3**
MCL-9 2.9 4.8 ± 1 1.9 ± 0.1**
MCL-13 4.0 1.8 ± 1 1.8 ± 0.7**
MCL-14 3.7 10 ± 2 1.0 ± 0.1**
MCL-16 4.5 5.2 ± 1 1.0 ± 0.4**
MCL-19 4.5 4.1 ± 1.1 1.7 ± 0.9**
Carbamates MCL-38 3.6 4.3 ± 1 2.9 ± 0.6
MCL-39 3.2 3.3 ± 1 2.9 ± 1.4
Triazole MCL-64 4.0 2.2 ± 0.1 1.2 ± 0.5**
1

CLogP represents an estimation of the logarithm of partition coefficient [n-Octanol/water] as determined by ChemDraw;

2

Half-maximal lethal concentration. Data represents mean ± std (n = 3).

**

p < 0.01 represents significant differences between MCL analogs and MCL using one-way ANOVA and Dunnett’s multiple comparisons test used to compare MCL analogs to MCL.